Literature DB >> 15975924

Ras-ERK MAPK cascade regulates GATA3 stability and Th2 differentiation through ubiquitin-proteasome pathway.

Masakatsu Yamashita1, Ryo Shinnakasu, Hikari Asou, Motoko Kimura, Akihiro Hasegawa, Kahoko Hashimoto, Naoya Hatano, Masato Ogata, Toshinori Nakayama.   

Abstract

Differentiation of naive CD4 T cells into Th2 cells requires protein expression of GATA3. Interleukin-4 induces STAT6 activation and subsequent GATA3 transcription. Little is known, however, on how T cell receptor-mediated signaling regulates GATA3 and Th2 cell differentiation. Here we demonstrated that T cell receptor-mediated activation of the Ras-ERK MAPK cascade stabilizes GATA3 protein in developing Th2 cells through the inhibition of the ubiquitin-proteasome pathway. Mdm2 was associated with GATA3 and induced ubiquitination on GATA3, suggesting its role as a ubiquitin-protein isopeptide ligase for GATA3 ubiquitination. Thus, the Ras-ERK MAPK cascade controls GATA3 protein stability by a post-transcriptional mechanism and facilitates GATA3-mediated chromatin remodeling at Th2 cytokine gene loci leading to successful Th2 cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15975924     DOI: 10.1074/jbc.M502333200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

Review 1.  Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.

Authors:  Lie Wang; Yumei Xiong; Rémy Bosselut
Journal:  Semin Immunol       Date:  2010-10       Impact factor: 11.130

2.  Prenatal secondhand cigarette smoke promotes Th2 polarization and impairs goblet cell differentiation and airway mucus formation.

Authors:  Shashi P Singh; Sravanthi Gundavarapu; Juan C Peña-Philippides; Jules Rir-Sima-ah; Neerad C Mishra; Julie A Wilder; Raymond J Langley; Kevin R Smith; Mohan L Sopori
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

3.  ERK1 is important for Th2 differentiation and development of experimental asthma.

Authors:  Nicholas Goplen; Zunayet Karim; Lei Guo; Yonghua Zhuang; Hua Huang; Magdalena M Gorska; Erwin Gelfand; Gilles Pagés; Jacques Pouysségur; Rafeul Alam
Journal:  FASEB J       Date:  2012-01-18       Impact factor: 5.191

4.  IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs.

Authors:  Chien-Chang Chen; Takao Kobayashi; Koji Iijima; Fan-Chi Hsu; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2017-02-11       Impact factor: 10.793

Review 5.  Differentiation of effector CD4 T cell populations (*).

Authors:  Jinfang Zhu; Hidehiro Yamane; William E Paul
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

6.  TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6.

Authors:  Na-Ra Han; Hyun-A Oh; Sun-Young Nam; Phil-Dong Moon; Do-Won Kim; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  J Invest Dermatol       Date:  2014-04-21       Impact factor: 8.551

Review 7.  Transcriptional drivers of the T-cell lineage program.

Authors:  Ellen V Rothenberg
Journal:  Curr Opin Immunol       Date:  2012-01-19       Impact factor: 7.486

8.  Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2.

Authors:  Irina V Grigorieva; Samantha Mirczuk; Katherine U Gaynor; M Andrew Nesbit; Elena F Grigorieva; Qiaozhi Wei; Asif Ali; Rebecca J Fairclough; Joanna M Stacey; Michael J Stechman; Radu Mihai; Dorota Kurek; William D Fraser; Tertius Hough; Brian G Condie; Nancy Manley; Frank Grosveld; Rajesh V Thakker
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

Review 9.  Signals for the execution of Th2 effector function.

Authors:  Deborah J Fowell
Journal:  Cytokine       Date:  2009-02-23       Impact factor: 3.861

10.  Suppressive effect of CTB glycoprotein (75 kDa) on IL-4 expression in primary-cultured lymphocytes treated with di(2-ethylhexyl) phthalate.

Authors:  Phil-Sun Oh; Kye-Taek Lim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-14       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.